Glioblastoma: pathology, molecular mechanisms and markers

2015/05/05 by Kenneth Aldape, Gelareh Zadeh, Sheila Mansouri +2 · 28 citations
Medicine · Biochemistry, Genetics and Molecular Biology · #Glioma Diagnosis and Treatment #Sarcoma Diagnosis and Treatment #Chromatin Remodeling and Cancer

paper · doi:10.1007/s00401-015-1432-1

Cited by

• Management of glioblastoma: State of the art and future directions
• Exploring ncRNA-mediated regulation of EGFR signalling in glioblastoma: From mechanisms to therapeutics
• Cascade-Responsive Nanoparticles for Efficient CRISPR/Cas9-Based Glioblastoma Gene Therapy
• Label-Free Neurosurgical Pathology with Stimulated Raman Imaging. [europepmc]
• Advances in epigenetic glioblastoma therapy. [europepmc]
• Molecular markers in glioma. [europepmc]
• Diagnostic and Therapeutic Biomarkers in Glioblastoma: Current Status and Future Perspectives. [europepmc]
• NF-κB Signalling in Glioblastoma. [europepmc]
• Hi-C as a tool for precise detection and characterisation of chromosomal rearrangements and copy number variation in human tumours. [europepmc]
• Infiltrating T Cells Increase IDO1 Expression in Glioblastoma and Contribute to Decreased Patient Survival. [europepmc]
• Classification of pulmonary neuroendocrine tumors: new insights. [europepmc]
• Mining TCGA database for genes of prognostic value in glioblastoma microenvironment. [europepmc]
• The role of interleukin-6-STAT3 signalling in glioblastoma. [europepmc]
• Harnessing the immune system in glioblastoma. [europepmc]
• Challenges to curing primary brain tumours. [europepmc]
• Regorafenib induces lethal autophagy arrest by stabilizing PSAT1 in glioblastoma. [europepmc]
• A Role for NF-κB in Organ Specific Cancer and Cancer Stem Cells. [europepmc]
• Bromodomain inhibitor jq1 induces cell cycle arrest and apoptosis of glioma stem cells through the VEGF/PI3K/AKT signaling pathway. [europepmc]
• Advances in the Knowledge of the Molecular Biology of Glioblastoma and Its Impact in Patient Diagnosis, Stratification, and Treatment. [europepmc]
• RND2 attenuates apoptosis and autophagy in glioblastoma cells by targeting the p38 MAPK signalling pathway. [europepmc]
• Pathomic Fusion: An Integrated Framework for Fusing Histopathology and Genomic Features for Cancer Diagnosis and Prognosis. [europepmc]
• The CNS and the Brain Tumor Microenvironment: Implications for Glioblastoma Immunotherapy. [europepmc]
• A Systematic Review of Glioblastoma-Targeted Therapies in Phases II, III, IV Clinical Trials. [europepmc]
• Benzimidazoles induce concurrent apoptosis and pyroptosis of human glioblastoma cells via arresting cell cycle. [europepmc]
• Macrophage Reprogramming and Cancer Therapeutics: Role of iNOS-Derived NO. [europepmc]
• Challenges and Opportunities for Immunoprofiling Using a Spatial High-Plex Technology: The NanoString GeoMx ® Digital Spatial Profiler. [europepmc]
• Mechanisms of Resistance and Current Treatment Options for Glioblastoma Multiforme (GBM). [europepmc]
• Glioblastoma: An Update in Pathology, Molecular Mechanisms and Biomarkers. [europepmc]